Bengaluru SaaS Unicorn Slashes IPO Size, Ignites Investor Frenzy
Capillary Technologies is all set to launch its IPO on November 14, and the buzz is real. The Bengaluru-based SaaS firm has reduced its fresh issue to 345 crore from 430 crore, while the offer-for-sale portion dropped from 1.83 crore shares to 92.2 lakh shares. Market watchers say this bold move could spark a stampede among investors eager to get a piece of India’s rising tech unicorn.
From Startup to Global SaaS Leader
Founded in 2008 by Aneesh Reddy, Krishna Mehra, and Ajay Modani, Capillary Technologies serves over 390 brands across 46 countries, including Tata Digital, Aditya Birla Fashion, and Abbott Labs. Promoters hold 67.18% of the company, with public shareholders at 32.82%. Top global investors like Ronal Holdings, AVP Fund, Trudy Holdings, Filter Capital India Fund, and Schroders Capital have poured in their confidence, signaling massive growth potential.
Strong Financials Fuel Hype
In FY25, Capillary posted revenue of 598 crore rupees, a 14% rise from the previous year, and turned profitable with a net gain of 14.1 crore rupees after a loss of 68 crore in FY24. The company has raised $239 million in funding so far, positioning it as one of India’s most promising SaaS IPOs.
IPO Details Investors Can’t Ignore
The IPO, managed by Axis Capital, ICICI Securities, and JM Financial, will be listed on both BSE and NSE. Analysts predict that the reduced issue size could create oversubscription frenzy, potentially leading to huge gains for early investors.
Why Capillary Could Be a Game-Changer
This IPO is more than a listing—it signals the rise of profitable Indian SaaS startups in public markets. With global clients, strong backing, and a growing financial track record, Capillary could set a new benchmark for tech IPOs in India.
Don’t Blink, Or You’ll Miss It
As November 14 approaches, all eyes are on Capillary Technologies. With its reduced issue size, global footprint, and strong financials, investors and tech enthusiasts alike are watching this IPO closely. The question remains: will Capillary live up to the hype? One thing is clear—it’s already the talk of the town.
